... ComplicationsNovember 28 – 29, 2012 London, UK 8th Annual Personalized Medicine ConferenceNovember 28 – 29, 2012 Boston, MA, USAIDIBELL Cancer Conference on Personalized Cancer Medicine ... available. As further confirmation of the usefulness of prolonged VEGF inhibition, Dr Grothey reviewed the data on aflibercept, a soluble fusion protein and novel VEGF receptor antagonist. This agent ... titles on page 4 or 5 of this brochure to go through to the content page on AdisOnline.com2. Click on the yellow ‘Buy This Article’ button on the right-hand column 3. Login to your existing...